company background image
WX8 logo

WuXi AppTec DB:WX8 Stock Report

Last Price

€6.80

Market Cap

€21.2b

7D

3.0%

1Y

n/a

Updated

23 Dec, 2024

Data

Company Financials +

WX8 Stock Overview

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. More details

WX8 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance2/6
Financial Health6/6
Dividends3/6

My Notes

Capture your thoughts, links and company narrative

WuXi AppTec Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for WuXi AppTec
Historical stock prices
Current Share PriceCN¥6.80
52 Week HighCN¥9.40
52 Week LowCN¥3.16
Beta0.82
1 Month Change25.93%
3 Month Change42.86%
1 Year Changen/a
3 Year Change-61.36%
5 Year Change7.77%
Change since IPO109.48%

Recent News & Updates

Recent updates

Shareholder Returns

WX8DE Life SciencesDE Market
7D3.0%-3.1%-2.0%
1Yn/a-5.9%6.9%

Return vs Industry: Insufficient data to determine how WX8 performed against the German Life Sciences industry.

Return vs Market: Insufficient data to determine how WX8 performed against the German Market.

Price Volatility

Is WX8's price volatile compared to industry and market?
WX8 volatility
WX8 Average Weekly Movement16.1%
Life Sciences Industry Average Movement7.1%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.3%
10% least volatile stocks in DE Market2.4%

Stable Share Price: WX8's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: WX8's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
200038,134Ge Liwww.wuxiapptec.com

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic.

WuXi AppTec Co., Ltd. Fundamentals Summary

How do WuXi AppTec's earnings and revenue compare to its market cap?
WX8 fundamental statistics
Market cap€21.19b
Earnings (TTM)€1.06b
Revenue (TTM)€5.07b

20.2x

P/E Ratio

4.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
WX8 income statement (TTM)
RevenueCN¥38.50b
Cost of RevenueCN¥22.86b
Gross ProfitCN¥15.64b
Other ExpensesCN¥7.57b
EarningsCN¥8.06b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.79
Gross Margin40.61%
Net Profit Margin20.94%
Debt/Equity Ratio10.1%

How did WX8 perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

36%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 03:06
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

WuXi AppTec Co., Ltd. is covered by 53 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Linda LuBOCI Research Ltd.
Jiangqiao TongBOCI Research Ltd.
Yang LuoBOCI Research Ltd.